Clinical Trials

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT06600321 2026-03-31

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Phase 1 Recruiting

158 enrolled

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07377487 2026-03-30

INDIGO

EndocrineGastrointestinalNET

51 enrolled

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT05063565 2026-03-27

ROWAN

Phase 2 Active not recruiting

100 enrolled

Phase NA Active not recruiting

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

120 enrolled

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT07010315 2026-03-04

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

40 enrolled

Phase NA Active not recruiting

Fibrosis, Liver Diseases, Liver Neoplasms

NCT05196867 2026-02-24

Liver Cancer Prevention Randomized Control Trial

49 enrolled

Liver Cirrhosis, Liver Diseases

NCT04690972 2026-02-12

LivMOD

800 enrolled

Hepatitis D, Fibrosis, Hepatitis B, Hepatitis C, Liver Diseases, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT04341012 2026-01-26

Breath Analysis Based Disease Biomarkers

46 enrolled 5 charts

COVID-19, Liver Diseases, Liver Neoplasms

NCT06535399 2026-01-23

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

29 enrolled

Lymphoid

Liver Diseases, Lymphoma, Follicular

NCT06523608 2025-12-22

DETECT

600 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT04618692 2025-12-18

Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation

52 enrolled

Phase NA Not yet recruiting

Liver Diseases, Liver Neoplasms, Liver Failure

NCT07191548 2025-10-10

LIVERMET-IRE

50 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT04539717 2025-10-08

FAST (Focused Abbreviated Screening Technique)-MRI Study

Enrolling by invitation

820 enrolled

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Diseases

NCT06352528 2025-10-06

A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

18 enrolled

Lymphoid

Liver Diseases, Lymphoma, Follicular

NCT04727307 2025-09-30

AB-LATE02

Phase 2 Recruiting

202 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular, Liver Diseases

NCT07111130 2025-09-23

RE-BALANCE

90 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular, Liver Diseases

NCT07185360 2025-09-22

LIVER-TRACK

845 enrolled

Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Hepatic Insufficiency

NCT04525833 2025-09-19

Liver Disease and Other Systemic Diseases

15,000 enrolled

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Liver Diseases, Disease Progression, Carcinogenesis, Non-alcoholic Fatty Liver Disease

NCT07150624 2025-09-02

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Phase 4 Recruiting

96 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

1,800 enrolled

Phase NA Active not recruiting

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01047735 2025-07-11

TRIABETES

69 enrolled

Other

Behavior, Blindness, Body Weight, Cardiovascular Diseases, Death, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Disease, Hypertension, Inflammation, Insulin Resistance, Liver Diseases, Motor Activity, Myocardial Infarction, Neoplasms, Obesity, Obesity, Morbid, Weight Loss, Atherosclerosis, Renal Insufficiency, Non-alcoholic Fatty Liver Disease

NCT07053488 2025-07-08

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Phase 1/2 Recruiting

90 enrolled

Fatty Liver, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT04965259 2025-07-02

Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)

Active not recruiting

2,002 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT05339984 2025-06-27

LSM

150 enrolled

Fibrosis, Hypertension, Portal, Liver Diseases

NCT02908048 2025-04-06

Extracellular RNA Markers of Liver Disease and Cancer

Active not recruiting

1,810 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT04066153 2025-04-06

Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions

43 enrolled

Genitourinary

Heart Failure, Kidney Diseases, Liver Diseases, Lung Diseases, Neoplasms, Nervous System Diseases

NCT05233098 2025-03-06

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

6 enrolled 15 charts

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT06425198 2025-01-22

Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

37 enrolled

Lymphoid

Liver Diseases, Lymphoma, Follicular

NCT06526754 2024-12-18

Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors

64 enrolled

Liver Diseases

NCT04926376 2024-11-29

Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

8 enrolled

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Colorectal Neoplasms

NCT06126419 2024-11-20

Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

70 enrolled

Liver Diseases

NCT05817994 2024-11-19

REGAL

Withdrawn

Hepatitis, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure, Acute

NCT06061276 2024-09-23

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

40 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular, Liver Diseases

NCT03519074 2024-09-19

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

48 enrolled

Liver Diseases, Neoplasms

NCT02301104 2024-09-05

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

24 enrolled

Liver Diseases, Liver Neoplasms

NCT03814005 2024-09-05

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

MyeloidOther hematologic neoplasm

17 enrolled 33 charts

Liver Diseases, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Renal Insufficiency

NCT02112656 2024-08-20

OPTIMA

Phase 3 Completed

554 enrolled 9 charts

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT06070636 2024-08-09

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

30 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT05931068 2024-08-05

PRO-NRG

20 enrolled

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

NCT00113113 2024-08-02

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

54 enrolled

Liver Diseases, Neoplasms, Renal Insufficiency

NCT05053412 2024-08-02

HEPATIC

1,556 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT06501742 2024-07-15

HMCV

100 enrolled

Liver Diseases, Liver Neoplasms

NCT04518852 2024-06-25

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Phase 2 Completed

27 enrolled

NCT02508467 2024-04-12

A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

146 enrolled

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT04627012 2024-03-06

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

600 enrolled

Carcinoma, Hepatocellular, Liver Diseases

NCT05471596 2024-03-04

MWA

60 enrolled

Liver Diseases, Liver Neoplasms

NCT05184283 2023-12-07

Utilization of MAsS in Patients Undergoing LT for HCC

Terminated

11 enrolled